← FDA Drug Approvals (Drugs@FDA)
NYSTATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2025-03-21
Drug application
- FDA Application #
ANDA219527- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NYSTATIN
- Generic name
- NYSTATIN
- Active ingredients
- NYSTATIN
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2025-03-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown